Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Origin by Ocean is a Finnish biotechnology company that operates a biorefinery platform designed to convert seaweed and algae into sustainable, bio-based ingredients. The company's proprietary Nauvu® technology extracts high-value molecules such as alginates, fucoidans, and pigments, which serve as functional components in the pharmaceutical, cosmetic, and food industries. By harvesting invasive algae and sustainably farmed seaweed, Origin by Ocean addresses marine eutrophication while providing eco-friendly alternatives to petroleum-based chemicals. Their products are utilized in applications ranging from drug delivery systems and wound care to skin health and nutritional supplements. The company aims to scale its operations to create a circular ocean-based economy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Origin by Ocean.